Chen Zhang

Chen Zhang

Auto-generated profile, based on publicly available information

Chen Zhang

From the Department of Neurology (Z.W., Y.R., Jiamin Li, Jiameng Li, C.Z., J.H., Q.M.), Xuanwu Hospital, Capital Medical University, Beijing; National Center for Neurological Disorders (Z.W., Y.R., Jiamin Li, Jiameng Li, C.Z., J.H., Q.M.), Beijing; Zhejiang Provincial Center for Disease Control and Prevention (W.L.), Hangzhou; National Center for Chronic and Non-communicable Disease Control and Prevention (L.W., M.Z., P.Y.), Chinese Center for Disease Control and Prevention, Beijing, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2024 in Neurology
Verified
Journal Article
Open access
CZChen Zhang
Chen Zhang
WLWei Liu
Wei Liu
LWLijun Wang
Lijun Wang
FWFei Wang
Fei Wang
JLJiao Li
Jiao Li
JHJunwei Hao
Junwei Hao
Multiple sclerosis (MS) is the leading cause of neurologic disability in young adults, but the burden caused by MS in China is lacking. We aimed to comprehensively describe the prevalence and health loss due to MS by demographic and geographical variables from 1990 to 2019 across China. Data were obtained from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019). We used GBD methodology to systematically analyze the prevalence, disability-adjusted life-years (DALYs), years of life lost (YLLs), and years lived with disability (YLDs) due to MS by age, sex, and location from 1990 to 2019 in mainland China and its provinces. We also compared the MS burden in China with the world and other Group of 20 (G20) countries. In 2019, 42,571 (95% uncertainty interval [UI] 33,001-53,329) individuals in China had MS, which doubled from 1990. The age-standardized prevalence rate of MS was 2.32 per 100,000 (95% UI 1.78-2.91), which increased by 23.31% (95% UI 20.50-25.89) from 1990, with most of the growth occurring after 2010. There was a positive latitudinal gradient with the increasing prevalence from south to north across China. The total DALYs caused by MS were 71,439 (95% UI 58,360-92,254) in 2019, ranking China third among G20 countries. Most of the MS burden in China derived from premature mortality, with the higher fraction of YLLs than that at the global level and most other G20 countries. From 1990 to 2019, the age-standardized DALY and YLL rate had nonsignificant changes; however, the age-standardized YLD rate substantially increased by 23.33% (95% UI 20.50-25.89). The geographic distribution of MS burden varied at the provincial level in China, with a slight downward trend in the age-standardized DALY rates along with increasing Socio-Demographic Index over the study period. Although China has a low risk of MS, the substantial and increasing prevalent cases should not be underestimated. The high burden due to premature death and geographic disparity of MS burden reveals insufficient management of MS in China, highlighting the needs for increased awareness and effective intervention.

26 November 2024 in Neurology
Verified
Journal Article
Open access
ZWZixin Wang
Zixin Wang
YRYi Ren
Yi Ren
WLWei Liu
Wei Liu
JLJiamin Li
Jiamin Li
JLJiameng Li
Jiameng Li
QMQingfeng Ma
Qingfeng Ma
The incidence of stroke among young adults was rising globally, but the death burden of stroke in young adults in China is lacking. We aimed to examine the temporal trends in mortality and years of life lost (YLLs) caused by stroke among young adults from 2005 to 2020 across China. Based on the data from the National Mortality Surveillance System in China, we estimated the number and age-standardized rate of mortality and YLLs due to stroke and its subtypes among young adults aged 15–49 years during 2005–2020, for both China and its 31 mainland provinces. During 2005–2020, the age-standardized mortality rate of stroke among young adults aged 15–49 years in China decreased by 21.0%, from 5.9/100,000 to 4.7/100,000, and the YLL rate decreased from 286.9/100,000 to 229.5/100,000. The age-standardized mortality rate among young adults due to intracerebral hemorrhage (ICH) showed a significant downward trend with a decrease of 26.3% while that of ischemic stroke (IS) and subarachnoid hemorrhage (SAH) decreased by 4.5% and 0.6%, respectively. In 2020, the mortality rate of ICH was 3.5 times higher than that of IS (3.3/100,000 vs 0.9/100,000) among young adults in China. The male/female ratio of age-standardized mortality rate of stroke in young adults increased from 2.0 in 2005 to 3.1 in 2020. The age-standardized mortality rate of IS and SAH in young men increased by 11.0% and 2.5%, respectively. In 2020, Tibet (18.4/100,000), Jilin (10.4/100,000), and Qinghai (8.3/100,000) were the top 3 provinces holding the highest age-standardized mortality rate due to stroke among young adults. Tibet was found to have the highest mortality rate due to ICH and SAH while that of IS was higher in northeast China. In China, the death burden caused by ICH among young adults was substantially higher than that of IS. The increasing death burden of IS and SAH among young men requires special attention. Evidence-based intervention strategies are needed to improve the outcomes of stroke and alleviate the death burden due to stroke among young adults in Chinese population.

13 August 2026 in Journal of Stomatology Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
TLTao Li
Tao Li
ZCZhongmin Chen
Zhongmin Chen
ZLZheng Long
Zheng Long
CZChen Zhang
Chen Zhang